Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
Clinical trial NCT00425555 · COMPLETED
Trial details
- NCT number
- NCT00425555
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2013-06-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.